Aytu BioPharma Inc. (AYTU) Reports Q1 Loss, Tops Revenue Estimates

Aytu BioPharma Inc. (AYTU) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.2 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -33.33%. A quarter ago, it was expected that this company would post a loss of $0.02 per share when it actually produced a loss of $0.26, delivering a surprise of -1200%.Over the last four quarters, the company has no ...